Regen med therapeutic opportunities for fighting COVID-19
Open Access
- 27 August 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 10 (1), 5-13
- https://doi.org/10.1002/sctm.20-0245
Abstract
This perspective from a Regenerative Medicine Manufacturing Society working group highlights regenerative medicine therapeutic opportunities for fighting COVID‐19. This article addresses why SARS‐CoV‐2 is so different from other viruses and how regenerative medicine is poised to deliver new therapeutic opportunities to battle COVID‐19. We describe animal models that depict the mechanism of action for COVID‐19 and that may help identify new treatments. Additionally, organoid platforms that can recapitulate some of the physiological properties of human organ systems, such as the lungs and the heart, are discussed as potential platforms that may prove useful in rapidly screening new drugs and identifying at‐risk patients. This article critically evaluates some of the promising regenerative medicine‐based therapies for treating COVID‐19 and presents some of the collective technologies and resources that the scientific community currently has available to confront this pandemic.Keywords
Funding Information
- U.S. Department of Health and Human Services
- National Institutes of Health
- U.S. Department of Health and Human Services
- National Institutes of Health
This publication has 43 references indexed in Scilit:
- Cellular Immunotherapy for Septic Shock. A Phase I Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platformScientific Reports, 2017
- Human Umbilical Cord Mesenchymal Stromal Cells Improve Survival and Bacterial Clearance in Neonatal Sepsis in RatsStem Cells and Development, 2017
- Immuno-engineered organoids for regulating the kinetics of B-cell development and antibody productionNature Protocols, 2016
- A Molecular Genetic Basis Explaining Altered Bacterial Behavior in SpacePLOS ONE, 2016
- Use of the Syrian Hamster as a New Model of Ebola Virus Disease and Other Viral Hemorrhagic FeversViruses, 2012
- Mesenchymal Stem Cells Reduce Inflammation while Enhancing Bacterial Clearance and Improving Survival in SepsisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Space flight alters bacterial gene expression and virulence and reveals a role for global regulator HfqProceedings of the National Academy of Sciences of the United States of America, 2007
- A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lungThe Journal of Experimental Medicine, 2007
- Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian HamstersJournal of Virology, 2005